A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity. (2020)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41420-020-0258-3
PubMed Identifier: 32337072
Publication URI: http://europepmc.org/abstract/MED/32337072
Type: Journal Article/Review
Volume: 6
Parent Publication: Cell death discovery
ISSN: 2058-7716